{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:02:40Z","timestamp":1785229360380,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102310305"],"award-info":[{"award-number":["242102310305"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.toxicon.2026.109165","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:09:04Z","timestamp":1779811744000},"page":"109165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and durability of therapies for neurogenic lower urinary tract dysfunction: A network meta-analysis of Botulinum Toxin a, instillations, and neuromodulation"],"prefix":"10.1016","volume":"281","author":[{"given":"Beibei","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunyu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yage","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8648-5649","authenticated-orcid":false,"given":"Weisheng","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2026.109165_bib1","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.juro.2010.08.028","article-title":"Botulinum Toxin-A injections into neurogenic overactive Bladder-To include or exclude the trigone? A prospective, randomized, controlled trial","volume":"184","author":"Abdel-Meguid","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/17582024.2025.2488712","article-title":"Effect of neuromodulation on neurogenic bladder in women with multiple sclerosis: a pilot randomized controlled trial","volume":"15","author":"Atak \u00c7akir","year":"2025","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.toxicon.2026.109165_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14062021","article-title":"Botulinum toxin therapy: a comprehensive review on clinical and pharmacological insights","volume":"14","author":"Ayoub","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.toxicon.2026.109165_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/10790268.2020.1712892","article-title":"A single-blind randomized control trial of trigonal versus nontrigonal botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury","volume":"44","author":"Chen","year":"2021","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.toxicon.2026.109165_bib6","article-title":"Efficacy and safety of OnabotulinumtoxinA in patients with neurogenic detrusor overactivity: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Cheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2026.109165_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/bju.12266","article-title":"OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium","volume":"112","author":"Collins","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.toxicon.2026.109165_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/nau.20296","article-title":"Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study","volume":"25","author":"de Seze","year":"2006","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2026.109165_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ju.0000100385.93801.d4","article-title":"Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study","volume":"171","author":"de Seze","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/nau.25062","article-title":"AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)","volume":"42","author":"Denys","year":"2023","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2026.109165_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/nau.22954","article-title":"Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport W (AbobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor Overactivity (NDO): a randomised placebo-controlled phase IIa Study","volume":"36","author":"Denys","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2026.109165_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxicon.2012.07.137","article-title":"Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Dmochowski","year":"2013","journal-title":"Toxicon : official journal of the International Society on Toxinology"},{"key":"10.1016\/j.toxicon.2026.109165_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365590601068835","article-title":"Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity","volume":"41","author":"Ehren","year":"2007","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.toxicon.2026.109165_bib14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.toxicon.2026.109165_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12325-013-0054-z","article-title":"OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology","volume":"30","author":"Ginsberg","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.toxicon.2026.109165_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/JU.0000000000002235","article-title":"The AUA\/SUFU Guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/JU.0000000000002239","article-title":"The AUA\/SUFU Guideline on adult neurogenic lower urinary tract dysfunction: treatment and Follow-up","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global Burden of disease study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2026.109165_bib19","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib20","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/nau.21124","article-title":"Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele","volume":"30","author":"Horst","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2026.109165_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sc.2015.143","article-title":"Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity","volume":"54","author":"Hui","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.toxicon.2026.109165_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.urology.2008.12.085","article-title":"Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity","volume":"74","author":"Kajbafzadeh","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2026.109165_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00383-014-3503-0","article-title":"Functional electrical stimulation for management of urinary incontinence in children with myelomeningocele: a randomized trial","volume":"30","author":"Kajbafzadeh","year":"2014","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.toxicon.2026.109165_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2022.03.010","article-title":"Efficacy and safety of AbobotulinumtoxinA in patients with neurogenic detrusor overactivity incontinence performing regular clean intermittent catheterization: pooled results from two phase 3 randomized studies (CONTENT1 and CONTENT2)","volume":"82","author":"Kennelly","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxicon.2026.109165_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.urology.2004.11.021","article-title":"Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways","volume":"65","author":"Kim","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2026.109165_bib27","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.juro.2013.05.011","article-title":"Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study","volume":"190","author":"Krause","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib28","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/jpet.110.169342","article-title":"Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers","volume":"334","author":"Lawrence","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.toxicon.2026.109165_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0090-4295(02)02587-6","article-title":"Urodynamic effects of intravesical nociceptin\/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study","volume":"61","author":"Lazzeri","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2026.109165_bib30","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.juro.2006.07.025","article-title":"Daily intravesical instillation of 1 mg nociceptin\/orphanin FQ for the control of neurogenic detrusor overactivity:: a multicenter, placebo controlled, randomized exploratory study","volume":"176","author":"Lazzeri","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104252","article-title":"Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: a prospective randomized controlled study","volume":"68","author":"Marzouk","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.toxicon.2026.109165_bib32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/sj.bjp.0701774","article-title":"Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle","volume":"123","author":"McMurray","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2026.109165_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/nau.23009","article-title":"Intradetrusor injections of onabotulinum toxin A (botox\u00ae) 300 U or 200 U versus abobotulinum toxin A (dysport\u00ae) 750 U in the management of neurogenic detrusor overactivity: a case control study","volume":"36","author":"Peyronnet","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2026.109165_bib34","series-title":"Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by Treatment with BOTOX\u00ae in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity","article-title":"A multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the safety and efficacy of a single treatment with two dose levels of BOTOX\u00ae","author":"Register","year":"2006"},{"key":"10.1016\/j.toxicon.2026.109165_bib35","author":"Register"},{"key":"10.1016\/j.toxicon.2026.109165_bib36","author":"Register"},{"key":"10.1016\/j.toxicon.2026.109165_bib37","author":"Register","year":"2015","journal-title":"DUE TO SPINAL CORD INJURY OR MULTIPLE SCLEROSIS"},{"key":"10.1016\/j.toxicon.2026.109165_bib38","author":"Register"},{"key":"10.1016\/j.toxicon.2026.109165_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.juro.2016.04.046","article-title":"Long-term efficacy and safety of OnabotulinumtoxinA in patients with neurogenic detrusor overactivity who completed 4 years of treatment","volume":"196","author":"Rovner","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2024.03.026","article-title":"Summary of the 2024 update of the european association of urology guidelines on neurourology","volume":"85","author":"Sartori","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2005.04.012","article-title":"Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial","volume":"48","author":"Silva","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000350247","article-title":"Submucosal administration of OnabotulinumtoxinA in the treatment of neurogenic detrusor overactivity: pilot single-centre experience and comparison with standard injection into the detrusor","volume":"91","author":"S\u00e1mal","year":"2013","journal-title":"Urol. Int."},{"key":"10.1016\/j.toxicon.2026.109165_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fnins.2019.00119","article-title":"Bladder neuromodulation in acute spinal cord injury via transcutaneous tibial nerve stimulation: cystometrogram and autonomic nervous system evidence from a randomized control pilot trial","volume":"13","author":"Stampas","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.toxicon.2026.109165_bib44","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40265-025-02171-3","article-title":"Efficiency and safety of noninvasive and intravesical therapy for adult neurogenic lower urinary tract dysfunction: a systematic review and network meta-analysis of randomized controlled trials","volume":"85","author":"Wang","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.toxicon.2026.109165_bib45","first-page":"63","article-title":"The role of botulinum toxin A in treating neurogenic bladder","volume":"5","author":"Weckx","year":"2016","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.toxicon.2026.109165_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/iju.iju_352_23","article-title":"The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: a narrative review","volume":"40","author":"Welk","year":"2024","journal-title":"Indian J. Urol : IJU : journal of the Urological Society of India"},{"key":"10.1016\/j.toxicon.2026.109165_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.sc.3100505","article-title":"The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results","volume":"36","author":"Wiart","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.toxicon.2026.109165_bib48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/0886022X.2019.1655448","article-title":"Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis","volume":"41","author":"Wu","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.toxicon.2026.109165_bib49","first-page":"R935","article-title":"Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion","volume":"276","author":"Yokoyama","year":"1999","journal-title":"Am. J. Physiol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126001832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126001832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:17:07Z","timestamp":1785226627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010126001832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0041010126001832"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109165","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and durability of therapies for neurogenic lower urinary tract dysfunction: A network meta-analysis of Botulinum Toxin a, instillations, and neuromodulation","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109165"}}